Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
A man in his 70s with stage 4 chronic kidney disease and atrial fibrillation presented with 1 month of progressive dyspnea on exertion, orthopnea, and worsening lower extremity edema. What is your diagnosis?
This phenome-wide association study determines polygenic predictors of thyrotropin levels and atrial fibrillation.
This Viewpoint discusses the use of electrocardiogram screening for atrial fibrillation, particularly in light of the US Preventive Services Task Force’s “insufficient evidence” recommendation regarding screening.
This mendelian randomization study evaluates the relationship between thyroid traits and atrial fibrillation.
This nested case-control study of patients with early-onset atrial fibrillation (AF) used large-scale, deep-coverage whole-genome sequencing to identify a loss-of-function variant in TTN, the gene encoding the rare nerve protein titin, as a genetic risk factor for early AF.
This study examines the incidence of atrial fibrillation in a cohort of elite athletes.
This cohort study uses data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II to assess racial/ethnic differences in the use of oral anticoagulants by patients with atrial fibrillation.
This comparative effectiveness analysis assesses the efficacy and safety of oral anticoagulants dabigatran, rivaroxaban, and warfarin in elderly Medicare beneficiaries with atrial fibrillation (AF) and multiple chronic conditions.
This cohort study compares the prevalence of family history of atrial fibrillation (AF) in patients of European, African, and Hispanic/Latino descent with early-onset AF vs non–early-onset AF.
A man presents with acute-onset aphasia, hemiplegia, and fever after a thoracoscopic ablative procedure for atrial fibrillation. What is your diagnosis?
This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening for atrial fibrillation using electrocardiography.
This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on screening for atrial fibrillation (AF) with electrocardiography (ECG) summarizes published evidence on the benefits and harms of screening and treatment of nonvalvular AF in asymptomatic adults 65 years and older.
This 2018 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for atrial fibrillation (AF) with ECG (I statement).
This cohort study uses Taiwan National Health Insurance database data to evaluate the incidence of ischemic stroke, hospitalization for heart failure, and all-cause mortality among patients with atrial fibrillation and atrial flutter stratified by CHA2DS2-VASc score.
This cohort study investigates whether mineralocorticoid receptor antagonist therapy or surgical adrenalectomy in patients with primary aldosteronism influences their risk for incident atrial fibrillation.
This population-based cohort study of UK Biobank data investigates the association of combined health behaviors and factors within genetic risk groups for coronary artery disease, atrial fibrillation, stroke, hypertension, and type 2 diabetes among UK adults.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: